# An Inflammatory Challenge Using Endotoxin

> **NCT04310423** · PHASE2 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 20 (actual)

## Conditions studied

- Alcohol Use Disorder
- Inflammatory Response
- Craving
- Depressed Mood

## Interventions

- **DRUG:** Placebo
- **BIOLOGICAL:** Endotoxin

## Key facts

- **NCT ID:** NCT04310423
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-19
- **Primary completion:** 2023-11-14
- **Final completion:** 2023-11-14
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04310423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04310423, "An Inflammatory Challenge Using Endotoxin". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04310423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*